← SynDRA
HYDROXYFASUDIL
SynDRA canonical compound SYN0024276 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ROCK1 |
|---|
| Mechanism of action | Rho associated kinase inhibitor |
|---|
All known targets
- ROCK1
- CLCN2
- PKIA
- PRKACA
- ROCK2
Mechanisms of action (all sources)
- Rho associated kinase inhibitor
- CLCN2 ACTIVATOR
- ROCK1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PRKACB
- ULK1
- CCL2
- CLK1
- LRRK2
- PRKD2
- PKN1
- KCNH2
- PKN2
- ACAD10
- PRKACG
- OLA1
- PAK6
- PAK5
- PAK4
- PAK2
- PAICS
- OPA1
- NUAK2
- PASK
- NUAK1
- NTRK1
- NQO2
- NLK
- NEK9
- NEK7
- PARP1
- PDGFRB
- PKMYT1
- PIM1
- PKD1
- PIP4K2C
- PIP4K2A
- PIM3
- PKN3
- PIM2
- PLK1
- PDK1
- PHKG2
- PGRMC1
Cross-references
Synonyms
- Acid-activated omeprazole
- Hydroxy-Fasudil
- 1-(1-Hydroxy-5-isoquinolinesulfonyl)homopiperazine
- HA-1100
- 1-[(1,2-DIHYDRO-1-OXO-5-ISOQUINOLINYL)SULFONYL]HEXAHYDRO-1H-1,4-DIAZEPINE
- CHEMBL1233300
- Hexahydro-1-((1,2-dihydro-1-oxo-5-isoquinolinyl)sulfonyl)-1H-1,4-diazepine
- 5-(1,4-diazepane-1-sulfonyl)-1,2-dihydroisoquinolin-1-one
- HYDROXYFASUDIL;5-(1,4-diazepan-1-ylsulfonyl)-2H-isoquinolin-1-one
- 1H-1,4-Diazepine, hexahydro-1-((1,2-dihydro-1-oxo-5-isoquinolinyl)sulfonyl)-
- HFS
- 2etk
- 2erz
- AC1MI8J4
- SCHEMBL123699
- HA 1100
- EYH4AU7P63
- RefChem:789488
- 5-((1,4-Diazepan-1-yl)sulfonyl)isoquinolin-1(2H)-one
- 5-(1,4-diazepan-1-ylsulfonyl)-2H-isoquinolin-1-one
- MFCD01752417
- 5-[(1,4-Diazepan-1-yl)sulfonyl]isoquinolin-1(2H)-one
- Fasudil Hydroxy
- Fasudil Impurity L
- Hydroxyfasudil free base
- Hydroxyfasudil free base?
- UNII-EYH4AU7P63
- 5-(1,4-diazepan-1-ylsulfonyl)isoquinolin-1-ol
- orb1302996
- SCHEMBL1827528
- SCHEMBL29395466
- SCHEMBL29473349
- SCHEMBL30309462
- BDBM14031
- EX-A1499
- BDBM50027431
- BDBM50417686
Look up HYDROXYFASUDIL in the interactive SynDRA portal →